HCPLive

Ulcerative Colitis

Latest Headlines

Crowded Drug Field
Video Interview: Palak Trivedi, BSc, MBBS, MRCP, University in Birmingham, England, spoke about several drug candidates under review working to improve outcomes of liver blood tests at The International Liver Congress 2015, Vienna, Austria.
Liver Disease: A Puzzle with Many Pieces
In this video interview, Palak Trivedi, BSc, MBBS, MRCP, from the University of Birmingham Centre for Liver Research, United Kingdom, discussed the implications his research findings have for IBD patients at The International Liver Congress 2015 in Vienna, Austria.
FDA Authorizes Phase 3 Clinical Trial for Pediatric Crohn’s Disease Therapy
Soligenix, Inc., a late-stage biopharmaceutical company, recently announced that the US Food and Drug Administration (FDA) authorized a pivotal Phase 3 clinical trial to assess the efficacy of novel drug SGX203, a pediatric Crohn’s disease (CD) therapy.
New York City to Allow Medical Marijuana Treatment for IBD Patients
Inflammatory Bowel Disease (IBD) has successfully made the exclusive list of conditions New York State deems appropriate to be treated with medical marijuana.

Most Popular

$vacMongoViewPlus$ $vAR$